iBio competitors

iBio Competitors include Lexicon Pharmaceuticals, Oxford Genetics, Spring Bank Pharmaceuticals and Arbutus Biopharma.
Add company...
iBio
iBio
iBio is a technology platform that develops pharmaceutical product applications.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Oxford Genetics
Oxford Genetics
Oxford Genetics is a synthetic biology company, specializes in DNA design, protein expression optimization, and cell line development technologies and services.
Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals
Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.
Arbutus Biopharma
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Founding Date
Founding Date
2008
Founding Date
1995
Founding Date
2011
Founding Date
2002
Founding Date
1992
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Newark, US HQ
Locations
Spring, US HQ
Jersey, JE
Washington, US
Tucson, US
The Woodlands, US
Tampa, US
Seattle, US
see more
Locations
Oxford, GB HQ
Locations
Hopkinton, US HQ
Milford, US
Locations
Burnaby, CA HQ
Warminster, US
Employees
Employees
43
Employees
1744% increase
Employees
54
Employees
15
Employees
1307% increase
Valuation ($)
Valuation ($)
12.9 m
Valuation ($)
769 m
Valuation ($)
N/A
Valuation ($)
164.7 m
Valuation ($)
243 m
Twitter followers
Twitter followers
N/A
Twitter followers
108
Twitter followers
665
Twitter followers
1.2 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$444k (FY, 2018)
Revenue (est.)
$90.3m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$10.7m (FY, 2017)
Net income
Net income
N/A
Net income
N/A
Net income
N/A
Net income
($27.7m) (FY, 2017)
Net income
($84.4m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 9.3m
Total funding raised
$ 244.7m
Total funding raised
N/A
Total funding raised
$ 14.4m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Lexicon Pharmaceuticals
HQ
Spring, US
Employees
174↑ 4% increase

Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.

View company
Oxford Genetics
HQ
Oxford, GB
Employees
54

Oxford Genetics is a synthetic biology company, specializes in DNA design, protein expression optimization, and cell line development technologies and services.

View company
Spring Bank Pharmaceuticals
HQ
Hopkinton, US
Employees
15

Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.

View company
Arbutus Biopharma
HQ
Burnaby, CA
Employees
130↑ 7% increase

Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.

View company